Heart shunt device aims to boost energy in failing hearts

NCT ID NCT07555925

Not yet recruiting Disease control Sponsor: Heinrich-Heine University, Duesseldorf Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a small device called an interatrial shunt that is placed in the heart to relieve pressure. It involves 15 adults with advanced heart failure and reduced pumping ability. Researchers will use advanced heart scans and exercise tests to see if the device improves heart energy and function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Interatrial shunt device (Ventura IASD)
What this could lead to: If successful, this device could help the heart pump more efficiently and reduce symptoms like shortness of breath in people with heart failure.
What could go wrong: This is a very small early study with only 15 people, so results may not apply to everyone. The device is already approved for other uses, but its benefits for this specific heart failure type are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospital Duesseldorf

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Contact

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.